ACTA2 and renal fibrosis: Moreover, RNA-seq analysis revealed that the SVF-treated group exhibited significantly reduced expression levels of Fn1, Col1a2, and Acta2, suggesting that SVF may attenuate renal fibrosis progression (Figure 3F).